My Profile
Agnes Crane
Making a market in
Ideas
See all posts
Sun 29 Nov 2009 | 5:55 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Depomed, Inc
Depomed, Inc (DEPO.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
DEPO
on other exchanges
As of 27 Nov 2009
3.23
USD
Price Change
-0.12
Percent Change
-3.58%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Gosling, Matthew
38
2006
Vice President, General Counsel
Sweeney, Michael
48
2007
Vice President - Research & Development
Callahan, William
--
2009
Vice President - Operations
Weisbrich, Shay
--
2009
Vice President - Marketing
Cameron, Tammy
43
2008
Vice President - Finance
Pelzel, Carl
58
2007
President, Chief Executive Officer, Director
Burrill, G. Steven
64
1997
Director
Stern, Julian
84
2001
Director
Staple, Peter
57
2003
Director
Zenoff, David
71
2007
Director
Schoeneck, James
51
2007
Director
Dawes, Karen
57
2008
Director
Smith, Craig
63
2007
Chairman of the Board
Find out more about DEPO.O
Insider Trading